Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Net Income towards Common Stockholders (2021 - 2025)

Incannex Healthcare's Net Income towards Common Stockholders history spans 3 years, with the latest figure at -$6.5 million for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders fell 10.64% to -$6.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$48.5 million, a 103.98% decrease, with the full-year FY2025 number at -$46.9 million, down 154.0% from a year prior.
  • Net Income towards Common Stockholders hit -$6.5 million in Q4 2025 for Incannex Healthcare, down from -$6.4 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for IXHL hit a ceiling of -$726000.0 in Q3 2023 and a floor of -$31.6 million in Q2 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$7.8 million across 3 years, with a median of -$6.0 million in 2024.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 646.56% in 2024 and later skyrocketed 34.21% in 2025.
  • Tracing IXHL's Net Income towards Common Stockholders over 3 years: stood at -$5.2 million in 2023, then dropped by 12.46% to -$5.9 million in 2024, then fell by 10.64% to -$6.5 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for IXHL at -$6.5 million in Q4 2025, -$6.4 million in Q3 2025, and -$31.6 million in Q2 2025.